During the past decade, Altay Regional Oncology Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Altay Regional Oncology Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Altay Regional Oncology Center" are "Renal Cell Carcinoma" (2 trials), "Bladder Cancer" (1 trials), "Castration-resistant Prostate Cancer" (1 trials), "Metastatic Prostate Cancer" (1 trials) and "Metastatic Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Altay Regional Oncology Center" in a lesser frequency.

Most popular intervention types in "Altay Regional Oncology Center" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abiraterone" (1 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Docetaxel" (1 trials), "Enzalutamide" (1 trials) and "HC-1119" (1 trials). Other intervention names were less common.

The vast majority of trials in "Altay Regional Oncology Center" are 3 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Altay Regional Oncology Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Altay Regional Oncology Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Altay Regional Oncology Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".